{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:05:02Z","timestamp":1747170302364,"version":"3.40.5"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":148,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.rmcr.2024.102058","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T13:20:33Z","timestamp":1717593633000},"page":"102058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Improvement in idiopathic interstitial pneumonia by adding macitentan to a patient unresponsive to nintedanib"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4965-7030","authenticated-orcid":false,"given":"Yosuke","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Kaburaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kamio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Okano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Seike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2024.102058_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0889-857X(21)00070-3","article-title":"Immune manifestations of inflammatory muscle disease","volume":"20","author":"Targoff","year":"1994","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.rmcr.2024.102058_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/art.1780350415","article-title":"Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease","volume":"35","author":"Hirakata","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmcr.2024.102058_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogenous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine"},{"key":"10.1016\/j.rmcr.2024.102058_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Poly- myositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"Q. J. Med."},{"key":"10.1016\/j.rmcr.2024.102058_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0014-2999(92)90387-J","article-title":"Release of endothelin in the oleic acid-induced respiratory distress syndrome in rats","volume":"211","author":"Simmet","year":"1992","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.rmcr.2024.102058_bib6","first-page":"49","article-title":"The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis","volume":"24","year":"2010","journal-title":"Jeffrey J Swigris, Kevin K Brown"},{"issue":"2","key":"10.1016\/j.rmcr.2024.102058_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1165\/ajrcmb.16.2.9032126","article-title":"Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines","volume":"16","author":"Saleh","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.rmcr.2024.102058_bib8","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"Latin American thoracic association: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmcr.2024.102058_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.200705-732OC","article-title":"A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"177","author":"King","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmcr.2024.102058_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1164\/rccm.201011-1874OC","article-title":"BUILD-3: a randomized, controlled trial of bosentan in idiopatic pulmonary fibrosis","volume":"184","author":"King","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.rmcr.2024.102058_bib11","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmcr.2024.102058_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201403-0446OC","article-title":"Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia","volume":"190","author":"Corte","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.rmcr.2024.102058_bib13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/ajrccm.156.2.9607123","article-title":"Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist","volume":"156","author":"Park","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmcr.2024.102058_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/FJC.0000000000000296","article-title":"Comparison of macitentan and bosentan on right ventricular remodeling in a rat model of non-vasoreactive pulmonary hypertension","volume":"66","author":"Iglarz","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.rmcr.2024.102058_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01287-2018","article-title":"Is there a role for endothelin-1 receptor antagonists in the treatment of lung fibrosis associated with pulmonary hypertension?","volume":"52","author":"Grune","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmcr.2024.102058_bib16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.rmed.2008.02.002","article-title":"Vaso-active therapy can improve 6-min walk distance in patients with pulmonary hypertension and fibrotic interstitial lung disease","volume":"102","author":"Minai","year":"2008","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2024.102058_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12890-017-0523-2","article-title":"Potential benefit of bosentan therapy in borderline or less severe pulmonary hypertension secondary to idiopathic pulmonary fibrosis-an interim analysis of results from a prospective, single-center, randomized, parallel-group study","volume":"17","author":"Tanaka","year":"2017","journal-title":"BMC Pulm. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2024.102058_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF01728331","article-title":"Endothelin production in sepsis and the adult respiratory distress syndrome","volume":"22","author":"Sanai","year":"1996","journal-title":"Intensive Care Med."},{"issue":"25_S","key":"10.1016\/j.rmcr.2024.102058_bib19","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007124000819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007124000819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T13:33:17Z","timestamp":1720791197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007124000819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":19,"alternative-id":["S2213007124000819"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2024.102058","relation":{},"ISSN":["2213-0071"],"issn-type":[{"type":"print","value":"2213-0071"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement in idiopathic interstitial pneumonia by adding macitentan to a patient unresponsive to nintedanib","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2024.102058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102058"}}